Skip to main content
SpringerLink
Log in

Dihydroartemisinin enhances radiosensitivity of human glioma cells in vitro

  • Original Paper
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Purpose: The antimalarial agent, artemisinin, also confers cancer-specific cytotoxic effects by reacting with ferrous iron atoms to form free radicals. Here, we investigated the radiosensitizing effects of dihydroartemisinin on glioma cells and assessed some possible mechanisms for these effects. Materials and methods: U373MG glioma cells treated with various concentrations of dihydroartemisinin plus radiation, and efficiency of radiosensitization was assessed by clonogenic survival assay. Expression and activity of antioxidant enzymes, glutathione-S-transferase (GST) were quantified by western blot and enzymatic activity analyses, respectively. Results: Dihydroartemisinin showed higher cytotoxicity in the glioma cell lines than in the liver, breast or cervical cancer cell lines. In clonogenic survival assays, treatment with dihydroartemisinin alone dose-dependently reduced the number of U373MG colonies, while treatment with dihydroartemisinin plus γ-irradiation showed far lower clonal survival than cultures treated with radiation or dihydroartemisinin alone. The radiosensitizing effect of dihydroartemisinin was blocked significantly by the free radical scavengers, NAC and TIRON, indicating association with dihydroartemisinin-induced ROS generation. In addition, the radiation-induced expression of endogenous GST was suppressed by treatment with dihydroartemisinin. The radiosensitizing effect of dihydroartemisinin was also markedly enhanced by the addition of holotransferrin Conclusion: Taken together, our results strongly suggest that dihydroartemisinin triggers production of ROS and inhibits GST activity, leading to effective and therapeutically relevant radiosensitization of human glioma cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  • Biaglow JE, Clark EP, Epp ER, Morse-Guadio M, Varnes ME, Mitchell JB (1983) Nonprotein thiols and the radiation response of A549 human lung carcinoma cells. Int J Radiat Biol 44:489–495

    Article  CAS  Google Scholar 

  • Brewer TG, Grate SJ, Peggins JO et al (1994) Fatal neurotoxicity of arteether and artemether. Am J Trop Med Hyg 51:251–259

    PubMed  CAS  Google Scholar 

  • Davis LW (1989) Malignant glioma—a nemesis which requires clinical and basic investigation in radiation oncology. Int J Radiat Oncol Biol Phys 16:1355–1365

    PubMed  CAS  Google Scholar 

  • Dell’Eva R, Pfeffer U, Vene R, Anfosso L, Forlani A, Albini A, Efferth T (2004) Inhibition of angiogenesis in vivo and growth of Kaposi’s sarcoma xenograft tumors by the anti-malarial artesunate. Biochem Pharmacol 68:2359–2366

    Article  PubMed  CAS  Google Scholar 

  • Efferth T, Volm M (2005) Glutathione-related enzymes contribute to resistance of tumor cells and low toxicity in normal organs to artesunate. In Vivo 19:225–232

    PubMed  CAS  Google Scholar 

  • Efferth T, Dunstan H, Sauerbrey A, Miyachi H, Chitambar CR (2001) The anti-malarial artesunate is also active against cancer. Int J Oncol 18:767–773

    PubMed  CAS  Google Scholar 

  • Efferth T, Davey M, Olbrich A, Rücher G, Gebbart E, Daveu R (2002) Activity of drugs from traditional Chinese medicine towards sensitive and MDRI- or MRPI-overexpressing multidrug-resistant human CCRF-CEM leukenna cells. Blood Cells Mol Dis 28:160–168

    Article  PubMed  Google Scholar 

  • Freeman BA, Crapo JD (1982) Biology of diseases: free radicals and tissue injury. Lab Invest 47:412–426

    PubMed  CAS  Google Scholar 

  • Hall EJ, Astor M, Bedford J, Borek C, Curtis SB, Fry M, Geard C, Hei T, Mitchell J, Oleinick N et al (1988) Basic radiobiology. Am J Clin Oncol 11:220–252

    Article  PubMed  CAS  Google Scholar 

  • Henderson CJ, McLaren AW, Moffat GJ, Bacon EJ, Wolf CR (1998) Pi-class glutathione S-transferase: regulation and function. Chem Biol Interact 111–112:69–82

    PubMed  Google Scholar 

  • Klayman DL (1985) Qinghaosu (artemisinin): an antimalarial drug from china. Science 228:1049–1055

    Article  PubMed  CAS  Google Scholar 

  • Lai H, Singh NP (1995) Selective cancer cell cytotoxicity from exposure to dihydroartemisinin and holotransferrin. Cancer Lett 91:41–46

    Article  PubMed  CAS  Google Scholar 

  • Lai H, Sasaki T, Singh NP, Messay A (2005) Effects of artemisinin-tagged holotransferrin on cancer cells. Life Sci 76:1267–1279

    Article  PubMed  CAS  Google Scholar 

  • Mahaley MS Jr, Mettlin C, Natarajan N, Laws ER Jr, Peace BB (1989) National survey of patterns of care for brain-tumor patients. J Neurosurg 71:826–836

    Article  PubMed  Google Scholar 

  • Moore JC, Lai H, Li JR, Ren RL, McDougall JA, Singh NP, Chou CK (1995) Oral administration of dihydroartemisinin and ferrous sulfate retarded implanted fibrosarcoma growth in the rat. Cancer Lett 27:83–87

    Google Scholar 

  • Mukanganyama S, Widersten M, Naik YS, Mannervik B, Hasler JA (2002) Inhibition of glutathione S-transferases by antimalarial drugs possible implications for circumventing anticancer drug resistance. Int J Cancer 97:700–705

    Article  PubMed  CAS  Google Scholar 

  • Onda K, Davis RL, Shibuya M, Wilson CB, Hoshino T (1994) Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas. Cancer 74:1921–1926

    Article  PubMed  CAS  Google Scholar 

  • Recht L, Torres CO, Smith TW, Raso V, Griffin TW (1990) Transferrin receptor in normal and neoplastic brain tissue: implications for brain-tumor immunotherapy. J Neurosurg 72:941–945

    PubMed  CAS  Google Scholar 

  • Repine JE, Pfenninger OW, Talmage DW, Berger EM, Pettijohn DE (1981) Dimethyl sulfoxide prevents DNA nicking mediated by ionizing radiation or iron/hydrogen peroxide-generated hydroxyl radical. Proc Natl Acad Sci USA 78:1001–1003

    Article  PubMed  CAS  Google Scholar 

  • Sadava D, Phillips T, Lin C, Kane SE (2002) Transferrin overcomes drug resistance to artemisinin in human small-cell lung carcinoma cells. Cancer Lett 179:151–156

    Article  PubMed  CAS  Google Scholar 

  • Scott MD, Meshnick SR, Eaton JW (1989) Superoxide dismutase amplifies organismal sensitivity to ionizing radiation. J Biol Chem 264:2498–2501

    PubMed  CAS  Google Scholar 

  • Shitara N, Kitamura K, Wada T, Nakamura H, Takata K (1989) Transferrin receptor molecules in human cell lines derived from the CNS malignant gliomas: immunohistochemical and flow-cytometric study. Acta Histochem Cytochem 22:275–288

    CAS  Google Scholar 

  • Shterman N, Kupfer B, Moroz C (1991) Comparison of transferring receptors, iron content and isoferritin profile in normal and malignant human breast cell lines. Pathobiology 59:19–25

    PubMed  CAS  Google Scholar 

  • Singh NP, Lai H (2001) Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells. Life Sci 70:49–56

    Article  PubMed  CAS  Google Scholar 

  • Taghian A, DuBois W, Budach W, Baumann M, Freeman J, Suit H (1995) In vivo radiation sensitivity of glioblastoma multiforme. Int J Radiat Oncol Biol Phys 32:99–104

    Article  PubMed  CAS  Google Scholar 

  • Van Agtmael MA, Eggelte TA, van Boxtel CJ (1999) Artemisinin drugs in the treatment of malaria: from medicinal herb to registered medication. Trends Pharmacol Sci 20:199–204

    Article  PubMed  Google Scholar 

  • Yamaguchi S, Sakurada S, Nagumo M (1994) Role of intracellular SOD in protecting leukemic and cancer cells against superoxide and radiation. Free Radic Biol Med 17:389–395

    Article  PubMed  CAS  Google Scholar 

  • Zovickian J, Johnson VG, Youle RJ (1987) Potent and specific killing of human malignant brain tumor cells by an anti-transferrin receptor antibody-ricin immunotoxin. J Neurosurg 66:850–861

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by the National Cancer Center grant 0410052-2.

Author information

Authors and Affiliations

  1. Research Institute and Hospital, National Cancer Center, 809 Madu-dong, Ilsan-gu, 411-769, Gyeonggi, Goyang, South Korea

    S. J. Kim, M. S. Kim, J. W. Lee, C. H. Lee, H. Yoo, S. H. Shin & S. H. Lee

  2. Laboratory of Functional Genomics, Korea Institute of Radiological & Medical Sciences, Seoul, South Korea

    M. J. Park

Authors
  1. S. J. Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. S. Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. W. Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. H. Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H. Yoo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S. H. Shin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. J. Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. S. H. Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. H. Lee.

Additional information

S.J. Kim·and M.S. Kim contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, S.J., Kim, M.S., Lee, J.W. et al. Dihydroartemisinin enhances radiosensitivity of human glioma cells in vitro. J Cancer Res Clin Oncol 132, 129–135 (2006). https://doi.org/10.1007/s00432-005-0052-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-005-0052-x

Keywords

Search

Navigation